About N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one
N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one (PubChem CID 158836068) has the molecular formula C76H102F3N15O9S
and a molecular weight of 1458.81 g/mol. Its IUPAC name is N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one.
Frequently Asked Questions
What is the IUPAC name of N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The IUPAC name of N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one (CID 158836068) is N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one.
What is the SMILES notation for N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The canonical SMILES for N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one is CCCCOc1nc(N)c2c(n1)N(Cc1cc(CN3CCCC3)cc(C(F)(F)F)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN(CC3CC3)C(C)=O)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN(CC3CC3)S(C)(=O)=O)c1)CCC(=O)C2.
What is the InChIKey of N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The InChIKey is IXQQFUVUPLUINN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N5O3.C25H32F3N5O2.C25H35N5O4S/c1-3-4-12-34-26-28-24(27)23-14-22(33)10-11-30(25(23)29-26)16-20-6-5-7-21(13-20)17-31(18(2)32)15-19-8-9-19;1-2-3-10-35-24-30-22(29)21-14-20(34)6-9-33(23(21)31-24)16-18-11-17(15-32-7-4-5-8-32)12-19(13-18)25(26,27)28;1-3-4-12-34-25-27-23(26)22-14-21(31)10-11-29(24(22)28-25)15-19-6-5-7-20(13-19)17-30(35(2,32)33)16-18-8-9-18/h5-7,13,19H,3-4,8-12,14-17H2,1-2H3,(H2,27,28,29);11-13H,2-10,14-16H2,1H3,(H2,29,30,31);5-7,13,18H,3-4,8-12,14-17H2,1-2H3,(H2,26,27,28).
What are the key properties of N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one has a molecular weight of 1458.81 g/mol, XLogP of 10.82, 29 rotatable bonds, 3 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)acetamide;N-[[3-[(4-amino-2-butoxy-6-oxo-7,8-dihydro-5H-pyrimido[4,5-b]azepin-9-yl)methyl]phenyl]methyl]-N-(cyclopropylmethyl)methanesulfonamide;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one is sourced from PubChem (CID 158836068), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).